The Defense Health Agency (DHA) is conducting market research to identify potential sources for providing Chemistry Analyzers at Eglin Air Force Base, Florida. The requirement includes delivering integrated chemistry and immune-chemistry platforms that comply with military standards, perform a specified range of tests, and ensure robust software capabilities, including interfaces with the DHA MHS GENESIS electronic health record system. This procurement is crucial for enhancing medical testing capabilities within the Department of Defense while adhering to regulatory standards, including HIPAA for the protection of health information. Interested parties must submit their responses to the Request for Information (RFI) by 12:00 P.M. Central Time on May 1, 2025, and can direct inquiries to Robby Brinkmann at robert.t.brinkmann.civ@health.mil or Marcus Mattingly at marcus.h.mattingly.civ@health.mil.